Prothena reported $50.6M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 116.57M 1.11M
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Akebia Therapeutics AKBA:US USD 187.96M 45.72M
ALKERMES ALKS:US USD 469.56M 31.04M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Amgen AMGN:US USD 14.33B 1.71B
Biogen BIIB:US USD 3.93B 1.09B
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Bluebird Bio BLUE:US USD 126.73M 22.13M
Exelixis EXEL:US USD 301.73M 2.79M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Intra Cellular Therapies ITCI:US USD 77.41M 6.78M
IONIS PHARMACEUT IONS:US USD 283.45M 15.64M
Macrogenics MGNX:US USD 50.05M 831K
Nektar Therapeutics NKTR:US USD 83.99M 21M
Neurocrine Biosciences NBIX:US USD 485.1M 199.4M
Prothena PRTA:US USD 50.6M 10.49M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Seattle Genetics SGEN:US USD 726M 117.48M
Ultragenyx Pharmaceutical RARE:US USD 227.36M 6.72M
Vertex Pharmaceuticals VRTX:US USD 2.61B 53.1M
Vital Therapies VTL:US USD 11.51M 1.11M
Xoma XOMA:US USD 5.42M 3M
YTE INCY:US USD 1.01B 79.92M